Ameriprise
BTMD icon

Ameriprise’s Biote Corp BTMD Stock Holding History

Ameriprise’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,621
Closed -$56.2K – 4077
2025
Q4 		$56.2K Hold
21,621
– – ﹤0.01% 4036
2025
Q3 		$64.9K Sell
21,621
-10,908
-34% -$39K ﹤0.01% 4005
2025
Q2 		$131K Buy
32,529
+2,737
+9% +$10.1K ﹤0.01% 3861
2025
Q1 		$99.2K Sell
29,792
-6,422
-18% -$30.6K ﹤0.01% 3881
2024
Q4 		$224K Buy
36,214
+3,351
+10% +$19.5K ﹤0.01% 3829
2024
Q3 		$183K Buy
32,863
+19,630
+148% +$131K ﹤0.01% 3767
2024
Q2 		$98.9K Buy
+13,233
New +$81.6K ﹤0.01% 3779

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's BTMD Position: Q1 2026 in Review

Ameriprise sold out of Biote Corp (BTMD) in Q1 2026, closing a stake of 21,621 shares — an estimated $56.2K sold.

Ameriprise first reported a position in BTMD in Q2 2024 and held it in 7 quarters. The position peaked at $224K in Q4 2024. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Ameriprise reported no remaining Biote Corp position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 21,621 Biote Corp shares in Q1 2026, an estimated $56.2K.
  • Ameriprise first reported a position in Biote Corp in Q2 2024 and held it in 7 quarters.
  • Ameriprise's Biote Corp position peaked at $224K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.